Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

Purchasing agreement in the US

Partnership accelerates Airon's US expansion

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company, announces that its US subsidiary, Airon Corporation ("Airon"), has entered into a significant new three-year purchasing agreement with a large US healthcare provider. This marks an important milestone for Airon's continued expansion in the US market.

Under the terms of the agreement, Airon will receive an initial order for 150 units of its Model A and Neo ventilators and accessories, reflecting a significant expansion to its installed base in the US.

This contract delivers a new long-term high quality revenue stream for Airon and directly supports Inspiration Healthcare's strategic goal of doubling Airon revenue within five years. Beyond initial equipment sales, the agreement includes expectations for ongoing consumables and service revenue, substantially increasing the lifetime value of the partnership.

Raffi Stepanian, CEO of Inspiration Healthcare, said: "This agreement validates our technology and execution capabilities on a national scale and is a transformative moment for Airon and for Inspiration Healthcare's US ambitions. We are pursuing further similar opportunities as part of our growth strategy for Airon."

Enquiries:

About Inspiration Healthcare

Inspiration Healthcare (AIM: IHC) designs, manufactures and markets pioneering medical technology. Based in the UK, the Company specialises in neonatal intensive care medical devices, which are addressing a critical need to help to save the lives and improve the outcomes of patients, starting with the very first breaths of life.

The Company has a broad portfolio of its own products and complementary distributed products, for use in neonatal intensive care designed to support even the most premature babies throughout their hospital stay. Its own branded products range from highly sophisticated capital equipment such as ventilators for life support through to single-use disposables.

The Company sells its products directly to hospitals and healthcare providers in the UK and Ireland, where it also distributes a range of advanced medical technologies for infusion therapy.  In the rest of the world the Company has an established network of distribution partners around the world giving access to more than 75 countries.

The Company operates in the UK from its world-class Manufacturing and Technology Centre in Croydon, South London and in the USA from its facility in Melbourne, Florida.

Further information on Inspiration Healthcare can be found at www.inspirationhealthcaregroup.com